Training

...

Training programs

Training programs

Leukemia is still poorly understood, even by oncology specialists. Research, ranging from identifying fundamental mechanisms of leukemogenesis to clinical trials, continuously generates new knowledge that must be shared with healthcare professionals—physicians and paramedical staff—researchers in the field, and scientists from other disciplines.

In partnership with our governing institutions—Paris Cité University, AP-HP, INSERM, and Collège de France—the Leukemia Institute’s training objectives are to:

  • Develop an online teaching platform

  • Create networks for training and scientific collaboration with other institutes in France, Europe, and beyond

  • Attract the best young physicians, healthcare professionals, and researchers through international programs

These initiatives will be led by our young physicians and researchers during dedicated time slots, thanks to the IHU’s support.

First Leukemia Institute symposium

Our past and upcoming seminars

5 June 2026 12:00 pm – 2:00 pm

INTER-IHU Seminar

Chrystelle Colas – Institut des Cancers des Femmes : Breast and Ovarian Cancer Predisposition: Beyond BRCA

Marie Sébert – Institut de la Leucémie : Germline predisposition to hematological malignancies, oncogenesis and emerging cancer susceptibility genes

Raphaël Ceccaldi – Institut des Cancers des Femmes : BRCA, Genome Stability and Targeted Therapy

Jean Soulier Institut de la Leucémie : Genomic instability as a preleukemia condition

9 January 2026 12:00 pm – 2:00 pm

Internal seminar

Céline Bonnet: Mathematical modelling to understand hematopoietic cells dynamics

David Michonneau: Corticosteroid resistance is predetermined by early immune response dynamics at acute Graft-Versus-Host disease onset

Olivier Kosmider: Is stromal inflammation in MDS and VEXAS syndrome a promising target?

21 November 2025 12:00 pm – 2:00 pm

Internal seminar

Julien Calvo: From Bone Marrow Adipose Tissue to Molecular Signatures: Unraveling Mechanisms of Chemoresistance in T-cell Acute Lymphoblastic Leukemia

Nabih MASLAH: Clonal selection and evolution in Myeloproliferative Neoplasms

Valéria BISIO: Unraveling Immune Interactions in Myelodysplastic Syndromes: Focus on Natural Killer Lymphocytes and Mesenchymal Stromal Cells

23 May 2025 12:00 pm – 2:00 pm

Internal seminar

Matthieu Duchmann: Early response dynamics to intensive chemotherapy treatment in AML patients – results from the DYNHAEMICS trial

Domitille Rérolle: Role of PML in Acute Myeloid Leukemia response to chemotherapy

Mathieu Simonin: Notching-up T-ALL

28 March 2025 12:00 pm – 2:00 pm

Internal seminar

Diana Passaro: Use of human organoids to unveil tissue specificity in acute lymphoblastic leukemia

Marie Sébert: DDX41-related hematopoietic malignancies

Marion Strullu: Two distinct fetal-type signatures characterize Juvenile Myelomonocytic Leukemia